Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Myasthenia Gravis 10Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1

Interventions

fludarabine 3Cyclophosphamide 3thymoglobulin 1prednylidene 1efgartigimod alfa 1deltacortene 1carmustine, poliferprosan 20 drug combination 1Prednisone 1Physical Therapy Modalities 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Etoposide 1Cytarabine 1Carmustine 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating × efgartigimod alfa × Clear all
NCT06299748 2026-02-17

A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.

argenx

Recruiting
279 enrolled

Myasthenia Gravis, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡